People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PierianDx, Inc. | — | Biotechnology | Series B | $41.9M | $443.4M | 2021 |
Barnard Buscemi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barnard Buscemi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Charles Boorady | 1 | 8 |
| Kerry Propper | 1 | 6 |
| Mark McDonough | 1 | 5 |
| Reid Robison | 1 | 4 |
| Michael Sanderson | 1 | 4 |
| Brian Carey | 1 | 3 |
| James Starr | 1 | 2 |
| Rakesh Nagarajan | 1 | 1 |
| Joseph Boorady | 1 | 1 |
| Frederick Hessler | 1 | 1 |
| Bryan Carey | 1 | 1 |
| Chris Callahan | 1 | 1 |
| Peter Jobse | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.